IDXG— INTERPACE BIOSCIENCES, INC.

Metric	FY2025	FY2024	FY2023	FY2022
Revenue, net	$38.7M-17.5%	$46.9M+17.2%	$40.0M+25.7%	$31.8M
Cost of revenue	$14.6M-14.1%	$17.0M+13.5%	$15.0M+10.1%	$13.6M
Gross profit	$24.1M-19.4%	$29.9M+19.4%	$25.1M+37.4%	$18.2M
Sales and marketing	$9.9M-14.9%	$11.7M+13.9%	$10.2M+12.1%	$9.1M
Research and development	$642K-5.0%	$676K+6.3%	$636K-9.5%	$703K
General and administrative	$9.5M-0.1%	$9.5M+1.3%	$9.4M-14.7%	$11.0M
Total operating expenses	$20.0M-8.1%	$21.8M+3.4%	$21.1M-3.4%	$21.8M
Operating income from continuing operations	$4.1M-49.6%	$8.1M+105.0%	$4.0M+209.4%	-$3.6M
Interest accretion expense	-$34K	—	-$112K+29.1%	-$158K
Note payable interest expense	-$168K+73.1%	-$625K+30.2%	-$896K-5.4%	-$850K
Other expense, net	-$142K+71.5%	-$499K+25.2%	-$667K+44.9%	-$1.2M
Income from continuing operations before tax	$3.8M-45.7%	$7.0M+204.7%	$2.3M+139.1%	-$5.8M
(Benefit) provision for income taxes	-$21.2M-530350.0%	$4K-76.5%	$17K-41.4%	$29K
Income from continuing operations	$25.0M+259.7%	$6.9M+206.8%	$2.3M+138.6%	-$5.9M
Loss from discontinued operations, net of tax	-$409K-67.6%	-$244K+21.3%	-$310K+98.1%	-$16.1M
Net income	$24.6M+266.7%	$6.7M+243.0%	$2.0M+108.9%	-$22.0M
Less adjustment for preferred stock deemed dividend	-$464K	—	—	—
Net income attributable to common stockholders	$24.6M+294.0%	$6.2M+219.2%	$2.0M	—
From continuing operations	$900+119.5%	$410-21.2%	$520+137.7%	-$1K
From discontinued operations	-$10+50.0%	-$20+71.4%	-$70+98.2%	-$4K
Net income (loss) per basic share of common stock	$5.55+290.8%	$1.42+215.6%	$0.45+108.7%	-$5.18
Net income (loss) per diluted share of common stock	$0.89+122.5%	$0.40-11.1%	$0.45+108.7%	-$5.18
Basic	$4.4M+0.8%	$4.4M+1.6%	$4.3M+1.9%	$4.2M
Diluted	$27.7M+76.0%	$15.7M+260.5%	$4.4M+3.0%	$4.2M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.